Covid-19: WHO publishes new guidelines
To protect against the wave of Covid-19 epidemics coming from China, the World Health Organization (WHO) presented its new guidelines on wearing a mask, the length of isolation and effective treatments against the virus on Friday 13 January.
An update of the prevention tools against the coronavirus. Concerned about the resurgence of cases seen in China in recent weeks, the World Health Organization (WHO) on Friday released its new guidelines on mask wearing, length of isolation and effective treatments against the virus.
The WHO published an update today #COVID-19 Guidelines to:
Wearing masks in community facilities
Find out more:
— World Health Organization (WHO) (@WHO) January 13, 2023
After China’s strict health restrictions ended last month, more than 60,000 hospital deaths swept the country between December 2022 and January 2023, according to an official announcement this Saturday.
Reinforcement of wearing the mask
Originally “based on the epidemiological situation”, WHO recommendations to wear a mask were reiterated this Friday. These are now based on risk situations, such as B. recent exposure to Covid-19, suspected infection or a person at high risk of severe forms. They also affect “any person in a crowded, enclosed, or poorly ventilated space”..
The WHO guidance will eventually track “local epidemiological trends or increased hospitalizations, the extent of vaccination coverage and immunity in the community and the context in which people find themselves,” the statement said.
Reduced isolation time
The health department recommends reducing the isolation of corona infected people if the antigen test is negative, but without specifying the duration of this reduction.
For patients who show symptoms of Covid-19 and do not have a test, the WHO recommends removing the three additional days of isolation after the symptoms have ended. That is, the initial ten days of isolation were retained, but the additional recommended three days after the end of symptoms are no longer relevant to the UN organization.
Finally, for anyone with a positive Covid-19 test without symptoms, the WHO recommends reducing the isolation time to five days, compared to the original ten days.
Paxlovid validated for the fight against Covid-19
In its press release, the WHO strongly recommends the use of nirmatrelvir-ritonavir, better known as “Paxlovid”. She only advises pregnant or breastfeeding women infected with Covid-19 to consult their doctor, touting “probable benefits” in the absence of side effects from the virus.
It should be noted that Paxlovid, recommended by the WHO from April 2022, shows improved efficacy in patients with a mild or moderate form of coronavirus who are at high risk of hospitalization.
However, the WHO advises against taking two drugs, sotrovimab and casirivimab-imdevimab. She judges that “these monoclonal antibody drugs have no or reduced activity against the viral variants currently circulating.”
Without revealing the names, the public health organization confirms the existence of six treatments that fight against Covid-19. Three of these aim to prevent high-risk people from being hospitalized. The other three aim to save the lives of people with serious or critical illnesses.